ASTRAZENECA PLC (AZN)
Clinical trial NCT06692738 updates: 1. completion date: 2029-10-08 → 2030-07-01 2. primary completion date: 2029-02-05 → 2030-07-01 3. enrollment: 880 → 1160 participants
Clinical trial NCT06692738 updates: 1. completion date: 2029-10-08 → 2030-07-01 2. primary completion date: 2029-02-05 → 2030-07-01 3. enrollment: 880 → 1160 participants
📉 **NEGATIVE** • Low confidence analysis (53%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (45%) **Content type:** Clinical